Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xin Hua, Fangfang Duan, Wenyu Zhai, Chenge Song, Chang Jiang, Li Wang, Jiajia Huang, Huanxin Lin & Zhongyu Yuan. (2022) A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer. Journal of Inflammation Research 15, pages 381-394.
Read now
Read now
Ming Zhao, Mingxin Zhang, Yonghua Wang, Xuecheng Yang, Xue Teng, Guangdi Chu, Xinsheng Wang & Haitao Niu. (2020) Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Muscle-Invasive Bladder Cancer After Radical Cystectomy. OncoTargets and Therapy 13, pages 13265-13274.
Read now
Read now
Zhi-Qing Long, Xin Hua, Wen-Wen Zhang, Shao-Wen Lv, Jia-Peng Deng, Ling Guo, Zhen-Yu He & Huan-Xin Lin. (2019) Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients. Cancer Management and Research 11, pages 4809-4814.
Read now
Read now
Articles from other publishers (32)
Madiha Liaqat, Rehan Ahmad Khan & Shahid Kamal. (2024) Comprehensive modelling of prostate cancer progression: integrating continuous and binary biomarkers with event time data and missing covariates. Discover Applied Sciences 6:2.
Crossref
Crossref
Yoanna S. Pumpalova, Adarsh Ramakrishnan, Michael May, Audrey Pentz, Shauli Minkowitz, Sean Doherty, Elvira Singh, Wenlong Carl Chen, Timothy R. Rebbeck, Alfred I. Neugut & Maureen Joffe. (2023)
Biochemical progression free and overall survival among Black men with stage
IV
prostate cancer in South Africa: Results from a prospective cohort study
. Cancer Medicine 13:1.
Crossref
Crossref
Rujiao Dong, Yudi Wang, Xiaohong Sun, Yuanyuan Lin, Yuqing Luo, Chongyun Xing, Lan Sun, Shenghui Zhang, Kang Yu, Songfu Jiang & Yi Chen. (2023) Significance of alkaline Phosphatase After Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 23:12, pages 911-916.
Crossref
Crossref
Zixuan Zhang, Junghyun Jung, Artem Kim, Noah Suboc, Steven Gazal & Nicholas Mancuso. (2023) A scalable approach to characterize pleiotropy across thousands of human diseases and complex traits using GWAS summary statistics. The American Journal of Human Genetics 110:11, pages 1863-1874.
Crossref
Crossref
Ming Li, Caiping Ding, Dong Zhang, Weiwei Chen, Zejun Yan, Zikang Chen, Zhiyong Guo, Longhua Guo & Youju Huang. (2023) Distinguishable Colorimetric Biosensor for Diagnosis of Prostate Cancer Bone Metastases. Advanced Science 10:32.
Crossref
Crossref
Angela Samy, Mohamed Ali Hussein & Gnanasekar Munirathinam. (2023) Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the β-catenin signaling pathway. Journal of Cancer Research and Clinical Oncology 149:11, pages 9085-9104.
Crossref
Crossref
Efthymios Papadopoulos, Andy Kin On Wong, Sharon Hiu Ching Law, Lindsey Ze Jing Zhang, Henriette Breunis, Urban Emmenegger & Shabbir M. H. Alibhai. (2023) The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer. PLOS ONE 18:6, pages e0286381.
Crossref
Crossref
Chukhu Muj, Satyajit Mukhopadhyay, Pritikana Jana & Anand K. Kondapi. (2023) Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer. Cancer Chemotherapy and Pharmacology 91:5, pages 375-387.
Crossref
Crossref
Daisuke Obinata, Sho Hashimoto, Hideaki Uchida, Ken Nakahara, Tsuyoshi Yoshizawa, Junichi Mochida, Kenya Yamaguchi & Satoru Takahashi. (2023) Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade. BMC Urology 23:1.
Crossref
Crossref
Katie Joanna Miller, Isla Henry, Zoe Maylin, Christopher Smith, Einthavy Arunachalam, Hardev Pandha & Mohammad Asim. (2023) A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer. Frontiers in Oncology 13.
Crossref
Crossref
Chengying Jiang, Fangke Hu, Xiaoqing Xia & Xiaojing Guo. (2023) Prognostic value of alkaline phosphatase and bone-specific alkaline phosphatase in breast cancer: A systematic review and meta-analysis. The International Journal of Biological Markers 38:1, pages 25-36.
Crossref
Crossref
Min Hyeong Son, Seok Won Park, Hee Yeon Sagong & Yun Kyung Jung. (2022) Recent Advances in Electrochemical and Optical Biosensors for Cancer Biomarker Detection. BioChip Journal 17:1, pages 44-67.
Crossref
Crossref
Riham M. Karkeet, Abdelrahman N. Zekri, Mohamed M. Sayed-Ahmed, Ghada M. Sherif, Salem E. Salem, Ahmed Abdelbary, Mariam A. Fouad & Sherif Y. Saad. (2022) The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial. PLOS ONE 17:12, pages e0278282.
Crossref
Crossref
Robin Wrenger, Michael Jüptner, Marlies Marx, Yi Zhao, Maaz Zuhayra, Amke Caliebe, Daniar Osmonov & Ulf Lützen. (2022) Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy. BMC Urology 22:1.
Crossref
Crossref
Renata Poteska, Kambiz Rahbar, Axel Semjonow, Andres Jan Schrader, Martin Boegemann & Katrin Schlack. (2022) The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide. BMC Cancer 22:1.
Crossref
Crossref
Benjamin Koa, William Y. Raynor, Peter Sang Uk Park, Austin J. Borja, Sachi Singhal, Angie Kuang, Vincent Zhang, Thomas J. Werner, Abass Alavi & Mona-Elisabeth Revheim. (2022) Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with 18F-Sodium Fluoride-PET/Computed Tomography. PET Clinics 17:4, pages 631-640.
Crossref
Crossref
Tasmeera Ebrahim, Bawinile Hadebe, Colleen Aldous, Partson Tinarwo & Nozipho Nyakale. (2022) Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7. Medicine 101:25, pages e29515.
Crossref
Crossref
Yu-Ting Li, Xiao-Shu Zhou, Xiao-Ming Han, Jing Tian, You Qin, Tao Zhang & Jun-Li Liu. (2022) Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer. World Journal of Gastrointestinal Oncology 14:5, pages 1002-1013.
Crossref
Crossref
Adree Khondker, Jethro CC Kwong, Christopher Tran, Emily Evans, Ishan Aditya, Lucshman Raveendran, Yingming A Chen, Amna Ali & Andrew Feifer. (2022) Incidence of dural metastases in castrate-resistant prostate cancer. Journal of Clinical Urology, pages 205141582210900.
Crossref
Crossref
Yuefu Han, Xingqiao Wen, Dong Chen, Xiaojuan Li, Qu Leng, Yuehui Wen, Jun Li & Weian Zhu. (2022) Survival Analysis and a Novel Nomogram Model for Progression-Free Survival in Patients with Prostate Cancer. Journal of Oncology 2022, pages 1-14.
Crossref
Crossref
Manivannan Madhu, Chien-Min Chao, Chen-Yi Ke, Ming-Mu Hsieh & Wei-Lung Tseng. (2022) Directed self-assembly of Ag+-deposited MoS2 quantum dots for colorimetric, fluorescent and fluorescence-lifetime sensing of alkaline phosphatase. Analytical and Bioanalytical Chemistry 414:5, pages 1909-1919.
Crossref
Crossref
I-Jung Tsai, Wen-Chi Shen, Chia-Ling Lee, Horng-Dar Wang & Ching-Yu Lin. (2022) Machine Learning in Prediction of Bladder Cancer on Clinical Laboratory Data. Diagnostics 12:1, pages 203.
Crossref
Crossref
Uğuray Aydos, Serhat Çetin, Ümit Özgür Akdemir, Fırat Çağlar Budak, Seda Gülbahar Ateş, Murat Yavuz Koparal, İpek Işık Gönül, Özlem Gülbahar, Sinan Sözen & Lütfiye Özlem Atay. (2021)
The role of histopathological and biochemical parameters for predicting metastatic disease on
68
Ga‐PSMA‐11 PET in prostate cancer
. The Prostate 81:16, pages 1337-1348.
Crossref
Crossref
Traian Constantin, Diana Alexandra Savu, Ștefana Bucur, Gabriel Predoiu, Maria Magdalena Constantin & Viorel Jinga. (2021) The Role and Significance of Bioumoral Markers in Prostate Cancer. Cancers 13:23, pages 5932.
Crossref
Crossref
Giulia Furesi, Martina Rauner & Lorenz C. Hofbauer. (2021) Emerging Players in Prostate Cancer–Bone Niche Communication. Trends in Cancer 7:2, pages 112-121.
Crossref
Crossref
Ying Li, Ruyuan Wang & Aiping Fan. (2020) Gold Nanocluster-catalyzed Luminol Chemiluminescent Sensing Method for Sensitive and Selective Detection of Alkaline Phosphatase. Analytical Sciences 36:9, pages 1075-1079.
Crossref
Crossref
Manuela Andrea Hoffmann, Hans-Georg Buchholz, Helmut J. Wieler, Matthias Miederer, Florian Rosar, Nicolas Fischer, Jonas Müller-Hübenthal, Ludwin Trampert, Stefanie Pektor & Mathias Schreckenberger. (2020) PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer. Cancers 12:2, pages 398.
Crossref
Crossref
Anna Yordanova, Paula Linden, Stefan Hauser, Georg Feldmann, Peter Brossart, Rolf Fimmers, Markus Essler, Stefan Holdenrieder & Hojjat Ahmadzadehfar. (2019)
The value of tumor markers in men with metastatic prostate cancer undergoing [
177
Lu]Lu‐PSMA therapy
. The Prostate 80:1, pages 17-27.
Crossref
Crossref
F. Li, J.-P. Ji, Y. Xu & R.-L. Liu. (2019) Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery. Clinical and Translational Oncology 21:8, pages 1067-1075.
Crossref
Crossref
AbdulFattah Salah Fararjeh & Yen-Nien Liu. (2019) ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences 20:11, pages 2802.
Crossref
Crossref
Carla Fernanda Furtado Gardani, Angélica Regina Cappellari, Julia Brandt de Souza, Bruna Tertuliano da Silva, Paula Engroff, Cesar Eduardo Jacintho Moritz, Juliete Nathali Scholl, Ana Maria Oliveira Battastini, Fabrício Figueiró & Fernanda Bueno Morrone. (2019) Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients. Purinergic Signalling 15:1, pages 95-105.
Crossref
Crossref
Fei Li, Yong Xu & Ran-Lu Liu. (2019) SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy. International Urology and Nephrology 51:3, pages 443-451.
Crossref
Crossref